Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Estrogen receptor (ER)-positive (ER+) tumors involve complex signaling pathways crucial for cancer progression.
• Understanding these pathways is key for developing biomarkers for treatment selection and predicting recurrence.
• Deficiencies in DNA repair capacity (DRC) are a common feature of breast cancer (BC).

Purpose of the Study:

• To investigate the influence of estrogen receptor (ER) signaling on DNA repair capacity (DRC) in breast cancer (BC).
• To analyze the association between ER positivity and DRC, stratified by HER2 receptor status.

Main Methods:

• Analysis of ER positivity and DRC in 270 BC patients.
• Stratification of analysis by HER2 receptor status.
• Statistical adjustment for potential confounding factors.

Main Results:

• A significant association between ER status and DRC was observed.
• Among HER2-negative patients, ER-negative status was linked to a higher likelihood of low DRC.
• A contrary pattern was noted in HER2-positive patients, indicating a modifying effect of HER2 status.

Conclusions:

• ER status and DRC are associated in BC, with the relationship modified by HER2 status.
• Integrating DRC testing with hormone receptor testing may offer insights into defective DNA repair phenotypes.
• This could enhance the stratification of ER+ BC patients, particularly ER+/HER2- subtypes, leading to improved treatment selection and outcomes.